CI
KITE

Capital International’s Kite Pharma, Inc. KITE Stock Holding History

Capital International’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-68,227
Closed -$7.07M – 124
2017
Q2 		$7.07M Hold
68,227
– – 0.47% 68
2017
Q1 		$5.36M Buy
68,227
+1,100
+2% +$68K 0.35% 78
2016
Q4 		$3.01M Buy
67,127
+7,327
+12% +$359K 0.21% 85
2016
Q3 		$3.34M Buy
+59,800
New +$3.33M 0.24% 91
2016
Q2 		– Sell
-16,500
Closed -$758K – 181
2016
Q1 		$758K Hold
16,500
– – 0.05% 145
2015
Q4 		$1.02M Hold
16,500
– – 0.06% 136
2015
Q3 		$919K Sell
16,500
-66,900
-80% -$4.21M 0.06% 132
2015
Q2 		$5.08M Hold
83,400
– – 0.3% 82
2015
Q1 		$4.81M Buy
83,400
+400
+0.5% +$26.8K 0.29% 80
2014
Q4 		$4.79M Buy
+83,000
New +$3.49M 0.29% 80

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International's KITE Position: Q3 2017 in Review

Capital International sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 68,227 shares — an estimated $7.07M sold.

Capital International first reported a position in KITE in Q4 2014 and held it in 10 quarters. The position peaked at $7.07M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Capital International reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Capital International sold 68,227 Kite Pharma, Inc. shares in Q3 2017, an estimated $7.07M.
  • Capital International first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 10 quarters.
  • Capital International's Kite Pharma, Inc. position peaked at $7.07M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Capital International's 13F filing for Q3 2017, filed 14 Nov 2017.